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The importance of the sense of smell is often unappreciated by patients and healthcare providers. Physical exams often report the status of cranial nerves II through XII, neglecting to mention cranial nerve I, the olfactory nerve. Although this nerve is not tested easily in most clinic settings, loss of olfactory function can have a substantial impact on a patient's quality of life and may be associated with, and possibly affect, overall health and longevity.
The chemosensory component of the U.S. National Health and Nutrition Examination Survey (NHANES) showed that 12.4%, or 13.3 million, U.S. adults aged ≥40 years had some degree of olfactory dysfunction. 1 The loss increased with age, with anosmia occurring in 12.7% of people aged 60 to 69 years and in 39.4% of those ≥80 years.
The loss of smell in the elderly results in safety concerns, as 20.3 and 31.3% of patients 70 years or older could not correctly identify smoke and natural gas, respectively. 1 The impact of this loss of smell can confound the effects of aging in general. Physiologic anorexia is common in the elderly, and olfactory loss may play a significant role in this phenomenon. 2 The ability to perceive the flavor of food is dependent on our retronasal smell (odors reaching the olfactory cleft via the oral and nasal pharynx), and deficits reduce food appreciation and appetite.
Olfactory loss is a significant predictor of 5-year mortality. 3 As part of the National Social Life, Health, and Aging Project, home-dwelling adults aged 57 to 85 years had their smell ability tested and were contacted and retested 5 years later. 4 Mortality rate was 3 to 4 times higher in anosmic subjects compared to normosmics, even when controlling for socioeconomic conditions and cognitive function. Those with normal cognition and difficulty identifying odors faced higher odds of being diagnosed with dementia, independent of other significant risk factors. 4 Many older patients, including those with cognitive decline, do not realize they have smell loss 5 and will not complain about it, especially if it has been present for several years. We can improve the sensitivity of selfreporting by asking slightly more detailed questions, 6 such as the following survey questions from the NHANES: A positive response to any of these questions can be considered a possible olfactory impairment. 7 Confirmation of this subjective report requires some objective testing, which is commercially available. One such test, the UPSIT (Sensonics; Haddon Heights, N.J.), is a "scratch and sniff" format with odors embedded in test strips; the patient is asked to identify the odor out of a choice of four possibilities. Sniffin' Sticks (Burghardt; Wedel, Germany), is another commercially available test in which the odor is contained in a series of felt-tip pens that can be reused for many months.
Smell training has helped to speed recovery of olfactory sensitivity, increasing olfactory function in approximately 30% of subjects. 8 This therapy involves taking a deep sniff of four odorants for 10 seconds twice a day. Patients who performed smell training showed significant improvement in smell sensitivity and smell discrimination after training, improvement in general mood, and a decline in depression symptoms. They showed improved semantic-categorical verbal fluency.
Olfactory training significantly improved general well-being scores on the WHO-Five Well-Being Index and was found to decrease depression. 9 These improvements in the emotional state of patients may be due to improved central nervous system connectivity, which appears to improve after smell training.
Smell loss appears to cause neural reorganization processes in the brain. Studies have shown evidence that gray and white matter decrease in patients with anosmia. 10 This reduction may be caused by a lack of sensory input. 11 Smell training appears to help reestablish functional connections in the olfactory areas of the brain. 11 Cranial nerve I has substantial impact on quality of life and may, if maintained properly, play a role in maintaining mental health in the geriatric population.
